REVERE PHARMACEUTICALS INC.

Profile

Company Names

REVERE PHARMACEUTICALS INC.

Addresses

36 ORVIS ROAD, ARLINGTON, MA 02474

Phone Numbers

781-718-9033

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$6,133,645.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2023-06-01 
$1,622,604.00 
$3,559,612.00 
$1,937,008.00 
Equity 
2
2021-08-27 
$1,056,199.00 
$1,999,999.00 
$943,800.00 
Equity 
1
2019-06-11 
$3,454,842.00 
$3,454,842.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEDD 
 
LEVINE 
DIRECTOR, EXECUTIVE OFFICER
REVERE PHARMACEUTICALS INC.
MARC 
 
LIPPMAN 
DIRECTOR
ASCENTA THERAPEUTICS, INC.   |  ONCOLOGY ANALYTICS, INC.   |  SPORTSGRID, INC.   |  REVERE PHARMACEUTICALS INC.   |  ALPHAGENERON PHARMACEUTICALS, INC.   |  RADIANCE BIOPHARMA, INC.
KOLLOL 
 
PAL 
DIRECTOR
MNEMOSYNE PHARMACEUTICALS INC   |  PYRAMID BIOSCIENCES, INC.   |  REVERE PHARMACEUTICALS INC.
IAN 
ROBERT 
SILVERMAN 
EXECUTIVE OFFICER, DIRECTOR
REVERE PHARMACEUTICALS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-06-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2023-06-01 
2021-09-01
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-27 
2021-01-12
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-11 
2020-06-22
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-11 
2019-06-21
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-11 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#